MARKET

JAZZ

JAZZ

Jazz Phrmt
NASDAQ

Real-time Quotes | Nasdaq Last Sale

137.62
+0.79
+0.58%
Closed 17:50 02/19 EST
OPEN
136.84
PREV CLOSE
136.83
HIGH
138.85
LOW
136.66
VOLUME
522.20K
TURNOVER
--
52 WEEK HIGH
154.24
52 WEEK LOW
116.52
MARKET CAP
7.79B
P/E (TTM)
13.17
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of JAZZ and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

JAZZ News

  • FDA accepts PharmaMar's lurbinectedin application for lung cancer
  • seekingalpha.1d ago
  • PharmaMar And Jazz Pharmaceuticals On Monday Announced FDA Acceptance And Priority Review Of New Drug Application For Lurbinectedin In Relapsed Small Cell Lung Cancer
  • Benzinga.1d ago
  • PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer
  • PR Newswire.3d ago
  • Could This Cancer Drug Developer�s Stock Make You Rich?
  • MotleyFool.com.5d ago

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.22%

Hot Stocks

Name
Price
%Change

About JAZZ

Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD). The Company also commercializes Prialt, an intrathecally administered infusion of ziconotide, approved by the FDA for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or intrathecal morphine.
More

Webull offers Jazz Pharmaceuticals PLC (JAZZ) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.